Results 161 to 170 of about 4,014 (178)

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly, 2023
openaire   +1 more source

Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.

Clinical Infectious Diseases, 2017
Shyam Kottilil, Susanna Naggie, Mark Sulkowski   +2 more
exaly  

Sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly, 2021
openaire   +1 more source

Sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly, 2022
openaire   +1 more source

Pharmacokinetic Drug Evaluation of Velpatasvir Plus Sofosbuvir for the Treatment of Hepatitis C Virus Infection

Expert Opinion on Drug Metabolism and Toxicology, 2017
Antonio Rivero, Antonio Rivero-Juarez
exaly  

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly, 2021
openaire   +1 more source

In Vitro Resistance Profile of Hepatitis C Virus NS5A Inhibitor Velpatasvir in Genotypes 1 to 6

Journal of Viral Hepatitis, 2019
Rudolf K Beran, Hadas Dvory-Sobol, Ross Martin   +2 more
exaly  

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials.

Clinical Infectious Diseases, 2016
Jason Grebely, Alessandra Mangia, Graham R Foster   +2 more
exaly  

Evaluation of Sofosbuvir, Velpatasvir Plus Voxilaprevir as Fixed-Dose Co-Formulation for Treating Hepatitis C

Expert Opinion on Drug Metabolism and Toxicology, 2017
Carmen de Mendoza, Pablo Barreiro, Vicente Soriano   +2 more
exaly  

Resistance Characterization of Ledipasvir and Velpatasvir in Hepatitis C Virus Genotype 4

Journal of Viral Hepatitis, 2018
Gregory Camus, Tarik Asselah, H Dvory-Sobol   +2 more
exaly